Search

everythinglearnresearchcommunity

for

Search:↓

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Minoxidil is mostly safe, but high doses can cause electrolyte imbalances and heart issues in dogs.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Early hair loss links to metabolic issues in young Indian men.

New treatments for lupus show promise, but more research is needed, especially for children.

Mediterranean diet with fresh herbs and vegetables lowers male hair loss risk.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A 28-year-old man with type 1 diabetes had skin and hair issues due to zinc deficiency.